{"id":"https://openalex.org/W2015081981","doi":"https://doi.org/10.1016/s0960-894x(01)80159-1","title":"Design, structure activity and x-ray crystallographic studies of pseudosymmetrical nonpeptidyl HIV-1 protease inhibitors","display_name":"Design, structure activity and x-ray crystallographic studies of pseudosymmetrical nonpeptidyl HIV-1 protease inhibitors","publication_year":1994,"publication_date":"1994-02-01","ids":{"openalex":"https://openalex.org/W2015081981","doi":"https://doi.org/10.1016/s0960-894x(01)80159-1","mag":"2015081981"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(01)80159-1","doi":"https://doi.org/10.1016/s0960-894x(01)80159-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(01)80159-1","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073199142","display_name":"Robert E. Babine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert E. Babine","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100331301","display_name":"Nan Zhang","orcid":"https://orcid.org/0000-0002-8309-4262","observed_orcids":["https://orcid.org/0000-0002-8309-4262"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nan Zhang","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111615455","display_name":"Steven R. Schow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven R. Schow","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108529043","display_name":"Zhang\u2010Bao Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhangbao Xu","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019994958","display_name":"Randal A. Byrn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Randal A. Byrn","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard C. Hastings","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard C. Hastings","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037542759","display_name":"Martin F. Semmelhack","orcid":"https://orcid.org/0000-0003-0277-3894","observed_orcids":["https://orcid.org/0000-0003-0277-3894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.F. Semmelhack","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032412455","display_name":"Michael M. Wick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael M. Wick","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060869676","display_name":"Suresh S. Kerwar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suresh S. Kerwar","raw_affiliation_strings":["Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Medicinal Chemistry Section American Cyanamic Company Medical Research Division Lederle Laboratories Pearl River, NY 10965 U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.5564,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.89444943,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"4","first_page":"583","last_page":"588"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.042500000447034836,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-protease-inhibitors","display_name":"HIV-1 protease inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9779999852180481},{"id":"https://openalex.org/keywords/antiretroviral-drug-design","display_name":"antiretroviral drug design","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8883377313613892},{"id":"https://openalex.org/C2779328170","wikidata":"https://www.wikidata.org/wiki/Q34777","display_name":"X-ray","level":2,"score":0.6538820862770081},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.5932687520980835},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5497971177101135},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.5225445628166199},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5220758318901062},{"id":"https://openalex.org/C50515024","wikidata":"https://www.wikidata.org/wiki/Q826582","display_name":"X-ray crystallography","level":3,"score":0.5046480894088745},{"id":"https://openalex.org/C115624301","wikidata":"https://www.wikidata.org/wiki/Q895901","display_name":"Crystal structure","level":2,"score":0.49997401237487793},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4538879692554474},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.4515683352947235},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3608246445655823},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2840769290924072},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24579134583473206},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.24216589331626892},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C207114421","wikidata":"https://www.wikidata.org/wiki/Q133900","display_name":"Diffraction","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0960-894x(01)80159-1","doi":"https://doi.org/10.1016/s0960-894x(01)80159-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(01)80159-1","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1541258411","https://openalex.org/W1966952510","https://openalex.org/W1967994100","https://openalex.org/W1973485456","https://openalex.org/W1993390869","https://openalex.org/W2009068086","https://openalex.org/W2013917043","https://openalex.org/W2019261111","https://openalex.org/W2027978582","https://openalex.org/W2047730466","https://openalex.org/W2058898122","https://openalex.org/W2123166384","https://openalex.org/W2140382609","https://openalex.org/W4252671483"],"related_works":["https://openalex.org/W2058898122","https://openalex.org/W2055129166","https://openalex.org/W2335148349","https://openalex.org/W1967994100","https://openalex.org/W2066316374","https://openalex.org/W1969352802","https://openalex.org/W2028585080","https://openalex.org/W1980935152","https://openalex.org/W2038353118","https://openalex.org/W2949633425"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}